The past, present, and future of HER2 (ERBB2) in cancer: Approaches to molecular testing and an evolving role in targeted therapy
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22124
Abstract: Jaclyn F. Hechtman is an assistant member of pathology at Memorial Sloan Kettering Cancer Center in New York City. She practices molecular and gastrointestinal pathology and also participates in assay validation for targetable molecular alterations… read more here.
Keywords: pathology; her2 erbb2; future her2; cancer ... See more keywords